Prevalence of neurotrophic tropomyosin receptor kinase ( NTRK ) fusion gene positivity in patients with solid tumors in Japan

Documenti analoghi

• Induction of resistance to neurotrophic tropomyosin‐receptor kinase inhibitors by HMGCS2 via a mevalonate pathway
  di: Yasuhiro Kato, et al.
  Pubblicazione: (2024)
• Spindle cell neoplasms with novel LTK fusion – Expanding the spectrum of kinase fusion‐positive soft tissue tumors
  di: Maximus C. F. Yeung, et al.
  Pubblicazione: (2024)
• Comparative Analysis of a Dual DNA – RNA Panel and a DNA ‐Only Panel for Sarcoma: Real‐World Data From a Nationwide Genomic Database
  di: Eiji Nakata, et al.
  Pubblicazione: (2025)
• Acute cardiotoxicity in pediatric and adolescent patients with solid tumors treated with tyrosine kinase inhibitors
  di: Jessica Gartrell, et al.
  Pubblicazione: (2025)
• Prevalence and prognosis of hypoxia‐inducible factor‐2α (HIF‐2α) pathway gene mutations across advanced solid tumors
  di: Wenjun Zhong, et al.
  Pubblicazione: (2024)